Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 6:57 pm Purchase | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 8,061,719 11% | 5,121,092 (+174.15%) | View |
| 2024-02-13 6:55 pm Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Bain Capital Life Sciences Fund L.P. | 16,915,784 11% | 4,713,274 (+38.63%) | View |
| 2024-01-22 4:30 pm Sale | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 1,967,093 3.8% | -918,173 (-31.82%) | View |
| 2023-06-23 4:34 pm Unchanged | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 7.1% | 0 (Unchanged) | View |
| 2023-05-30 5:00 pm Sale | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 2,940,627 5.5% | -1,945,989 (-39.82%) | View |
| 2023-02-14 06:41 am Purchase | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 4,886,616 11% | 1,945,989 (+66.18%) | View |
| 2023-02-14 06:34 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Bain Capital Life Sciences Fund L.P. | 12,202,510 11% | 9,315,968 (+322.74%) | View |
| 2022-08-17 5:00 pm Sale | 13D | DYNAVAX TECHNOLOGIES CORP COM DVAX | Bain Capital Life Sciences Fund L.P. | 4,912,610 3.9% | -2,721,435 (-35.65%) | View |
| 2022-08-08 4:49 pm Unchanged | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Bain Capital Life Sciences Fund L.P. | 2,721,436 4.5% | 0 (Unchanged) | View |
| 2022-05-27 4:19 pm Sale | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Bain Capital Life Sciences Fund L.P. | 2,721,436 5.3% | -888,360 (-24.61%) | View |
| 2022-02-14 06:39 am Purchase | 13G | X4 PHARMACEUTICALS INC XFOR | Bain Capital Life Sciences Fund L.P. | 2,886,542 11% | 1,238,057 (+75.10%) | View |
| 2022-02-14 06:37 am Purchase | 13G | RAPID MICRO BIOSYSTEMS INC RPID | Bain Capital Life Sciences Fund L.P. | 7,651,369 22.2% | 7,651,369 (New Position) | View |
| 2021-08-27 5:17 pm Sale | 13D | DYNAVAX TECHNOLOGIES CORP COM DVAX | Bain Capital Life Sciences Fund L.P. | 7,634,045 6.4% | -2,780,955 (-26.70%) | View |
| 2021-08-11 5:16 pm Sale | 13D | DYNAVAX TECHNOLOGIES CORP COM DVAX | Bain Capital Life Sciences Fund L.P. | 10,415,000 13% | -1,356,708 (-11.53%) | View |
| 2021-06-11 5:16 pm Purchase | 13D | DYNAVAX TECHNOLOGIES CORP COM DVAX | Bain Capital Life Sciences Fund L.P. | 11,771,708 13% | 875,935 (+8.04%) | View |
| 2021-03-26 4:16 pm Unchanged | 13D | APTINYX INC APTX | Bain Capital Life Sciences Fund L.P. | 8,066,113 12.1% | 0 (Unchanged) | View |
| 2021-02-19 4:30 pm Purchase | 13G | PHARVARIS N V REGISTERED PHVS | Bain Capital Life Sciences Fund L.P. | 2,885,266 9.1% | 2,885,266 (New Position) | View |
| 2021-02-16 3:28 pm Sale | 13G | MARINUS PHARMACEUTICALS INC MRNS | Bain Capital Life Sciences Fund L.P. | 1,298,178 3.6% | -4,092,744 (-75.92%) | View |
| 2021-02-16 3:21 pm Purchase | 13G | ANNEXON INC ANNX | Bain Capital Life Sciences Fund L.P. | 2,940,627 7.7% | 2,940,627 (New Position) | View |
| 2021-02-16 3:18 pm Sale | 13G | CONSTELLATION PHARMACEUTICALS CNST | Bain Capital Life Sciences Fund L.P. | 1,270,003 2.7% | -1,291,347 (-50.42%) | View |